THE USE OF FIBRINOLYTIC ACTIVATORS IN MENINGITIS AND SIMILAR CONDITIONS.
D001927:Brain Diseases; D002556:Cerebrospinal Fluid Proteins; D002648:Child; D003850:Deoxyribonuclease I; D004358:Drug Therapy; D005342:Fibrinolysis; D006801:Humans; D007223:Infant; D008581:Meningitis; D008585:Meningitis, Meningococcal; D008588:Meningocele; D010958:Plasminogen; D011512:Proteus Infections; D011552:Pseudomonas Infections; D013203:Staphylococcal Infections; D013299:Streptodornase and Streptokinase; D013300:Streptokinase
D002556:Cerebrospinal Fluid Proteins; D010958:Plasminogen; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase
BRAIN DISEASES; CEREBROSPINAL FLUID PROTEINS; CHILD; DRUG THERAPY; FIBRINOLYSIS; INFANT; MENINGITIS; MENINGITIS, MENINGOCOCCIC; MENINGOCELE; PLASMINOGEN; PROTEUS INFECTIONS; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STREPTODORNASE AND STREPTOKINASE